Sopharma AD-BG11SOSOBT18-SOPHARMA

SOPHARMA AD (6/2025) Individual financial report according to IFRS as of 31 December 2024

Report no 6/2025
- 30.01.2025, 14:21
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (5/2025) Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for receival of shares from the capital increase of Sopharma AD

Report no 5/2025
- 28.01.2025, 11:27
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (4/2025) Sales revenues for December 2024

Report no 4/2025
- 20.01.2025, 13:10
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (3/2025) Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212

Report no 3/2025
- 15.01.2025, 16:20
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (2/2025) Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024

Report no 2/2025
- 02.01.2025, 10:54
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (1/2025) Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024

Report no 1/2025
- 02.01.2025, 10:50
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (150/2024) Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Report no 150/2024
- 23.12.2024, 20:00
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (149/2024) Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Report no 149/2024
- 23.12.2024, 19:58
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (148/2024) Notification from Alexander Tchaoushev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Report no 148/2024
- 20.12.2024, 12:41
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (147/2024) Decision on additional contribution to the capital of Sopharma Rus OOO

Report no 147/2024
- 20.12.2024, 12:16
- Kategoria: Biznes i finanse
- Źródło: ESPI

Relacja z konferencji „Droga do prezydencji: dyskusja o priorytetach zdrowotnych polskiej prezydencji w Radzie UE”

Instytut Spraw Społecznych (1)